A scientist is testing the effects of the active ingredient in a new drug, known as Cure-All. Which of the following would best
serve as a control group in determining the active ingredient's effectiveness? a. A group of individuals treated with a placebo drug b. A group of individuals treated once a day with Cure-All c. A group of individuals treated twice a day with Cure-All d. A group of individuals treated with both Cure-All and an over-the-counter medication
cholinesterase inhibitors (Aricept, Exelon, Razadyne) and memantine (Namenda) to treat the cognitive symptoms memory loss, confusion, and problems with thinking and reasoning.
